These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34833992)

  • 1. Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex.
    Saumell-Esnaola M; Barrondo S; García Del Caño G; Goicolea MA; Sallés J; Lutz B; Monory K
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical characterization of the cannabinoid CB
    Gutiérrez-Rodríguez A; Puente N; Elezgarai I; Ruehle S; Lutz B; Reguero L; Gerrikagoitia I; Marsicano G; Grandes P
    J Comp Neurol; 2017 Feb; 525(2):302-318. PubMed ID: 27339436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
    Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
    Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
    Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K
    J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptor calibrates excitatory synaptic balance in the mouse hippocampus.
    Monory K; Polack M; Remus A; Lutz B; Korte M
    J Neurosci; 2015 Mar; 35(9):3842-50. PubMed ID: 25740514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling.
    Fukudome Y; Ohno-Shosaku T; Matsui M; Omori Y; Fukaya M; Tsubokawa H; Taketo MM; Watanabe M; Manabe T; Kano M
    Eur J Neurosci; 2004 May; 19(10):2682-92. PubMed ID: 15147302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: a comparison between the gray mouse lemur (Microcebus murinus, primates) and rat.
    Harkany T; Dobszay MB; Cayetanot F; Härtig W; Siegemund T; Aujard F; Mackie K
    Neuroscience; 2005; 135(2):595-609. PubMed ID: 16129564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.
    Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B
    J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons.
    Nyíri G; Cserép C; Szabadits E; Mackie K; Freund TF
    Neuroscience; 2005; 136(3):811-22. PubMed ID: 16344153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective up-regulation of cannabinoid CB
    Mato S; Pilar-Cuéllar F; Valdizán EM; González-Maeso J; Rodríguez-Puertas R; Meana J; Sallés J; Crespo-Facorro B; Pazos Á
    Biochem Pharmacol; 2018 Nov; 157():258-265. PubMed ID: 30099006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons.
    Harkany T; Härtig W; Berghuis P; Dobszay MB; Zilberter Y; Edwards RH; Mackie K; Ernfors P
    Eur J Neurosci; 2003 Oct; 18(7):1979-92. PubMed ID: 14622230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
    Chiarlone A; Bellocchio L; Blázquez C; Resel E; Soria-Gómez E; Cannich A; Ferrero JJ; Sagredo O; Benito C; Romero J; Sánchez-Prieto J; Lutz B; Fernández-Ruiz J; Galve-Roperh I; Guzmán M
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8257-62. PubMed ID: 24843137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
    Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
    J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA.
    Liang J; Kruijssen DLH; Verschuuren ACJ; Voesenek BJB; Benavides FFW; Sáez Gonzalez M; Ruiter M; Wierenga CJ
    J Neurosci; 2021 Oct; 41(40):8279-8296. PubMed ID: 34413209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
    Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
    J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway.
    Mai P; Tian L; Yang L; Wang L; Yang L; Li L
    J Cell Physiol; 2015 Jul; 230(7):1640-50. PubMed ID: 25545473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.